- Home
- HRTX vs NEWT Comparison
HRTX vs NEWT Comparison
Compare HRTX & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- NEWT
- Stock Information
- Founded
- HRTX 1983
- NEWT 1998
- Country
- HRTX United States
- NEWT United States
- Employees
- HRTX N/A
- NEWT N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- NEWT Major Banks
- Sector
- HRTX Health Care
- NEWT Finance
- Exchange
- HRTX Nasdaq
- NEWT Nasdaq
- Market Cap
- HRTX 350.4M
- NEWT 335.7M
- IPO Year
- HRTX 1987
- NEWT N/A
- Fundamental
- Price
- HRTX $2.11
- NEWT $10.38
- Analyst Decision
- HRTX Strong Buy
- NEWT Hold
- Analyst Count
- HRTX 2
- NEWT 4
- Target Price
- HRTX $5.50
- NEWT $14.00
- AVG Volume (30 Days)
- HRTX 1.8M
- NEWT 314.5K
- Earning Date
- HRTX 05-06-2025
- NEWT 05-06-2025
- Dividend Yield
- HRTX N/A
- NEWT 7.42%
- EPS Growth
- HRTX N/A
- NEWT 27.59
- EPS
- HRTX N/A
- NEWT 1.92
- Revenue
- HRTX $148,518,000.00
- NEWT $352,584,000.00
- Revenue This Year
- HRTX $11.18
- NEWT N/A
- Revenue Next Year
- HRTX $13.15
- NEWT $15.38
- P/E Ratio
- HRTX N/A
- NEWT $5.33
- Revenue Growth
- HRTX 12.43
- NEWT 23.06
- 52 Week Low
- HRTX $1.04
- NEWT $9.12
- 52 Week High
- HRTX $3.93
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- HRTX 47.04
- NEWT 46.89
- Support Level
- HRTX $2.00
- NEWT $9.62
- Resistance Level
- HRTX $2.61
- NEWT $10.26
- Average True Range (ATR)
- HRTX 0.18
- NEWT 0.43
- MACD
- HRTX -0.01
- NEWT 0.04
- Stochastic Oscillator
- HRTX 20.63
- NEWT 55.77
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions, It has developed a financial and technology-based business model that enables itself to acquire and process its clients in a very cost-effective manner. This capability is supported in large part by NewTracker, its patented prospect management technology software, that will allow NewtekOne clients to easily interact with NewtekOne subject matter experts in the areas of Banking, Lending, Payments, Technology, Payroll, and Insurance. It offers NewtekOne's clients a single online dashboard to access all of NewtekOne's business and financial solutions. It has four reportable segments Banking, Technology, NSBF, and Payments.